Real-time enrollment status for this acute cannabis-induced cns depression clinical trial
Current Status
Recruiting
Checked: September 6, 2026 at 6:37 AM UTC
| NCT Number | NCT06017622 |
| Recruiting Status | Recruiting |
| Condition | Acute Cannabis-induced CNS Depression |
| Phase | Clinical Trial |
| Target Enrollment | 36 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Anebulo Pharmaceuticals |
| Last Updated on CT.gov | July 30, 2026 (Jul 30, 2026) |
As of September 6, 2026: Clinical trial NCT06017622 is currently recruiting participants. This clinical trial study for acute cannabis-induced cns depression is actively seeking new participants at 3 locations across the United States. The study is sponsored by Anebulo Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06017622 is actively recruiting participants as of September 6, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06017622 was last updated Jul 30, 2026 (July 30, 2026). HelloStudys verifies this status automatically.